Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probioflor Complex is a next-generation synbiotic dietary supplement developed by Vector-BiAlgam. It is formulated as enteric-coated capsules containing a consortium of 10 probiotic strains, including bifidobacteria (such as *Bifidobacterium bifidum*, *Bifidobacterium longum*, and *Bifidobacterium breve*), lactobacilli (such as *Lactobacillus acidophilus*, *Lactobacillus plantarum*, *Lactobacillus casei*, and *Lactobacillus rhamnosus*), and *Streptococcus thermophilus*. The formulation also includes prebiotics such as lactulose, microcrystalline cellulose, and ascorbic acid (vitamin C). It is designed to restore and maintain healthy gut microbiota, displace pathogenic and opportunistic bacteria, support digestion, and enhance immune function. It is indicated for dysbiosis, gastrointestinal disorders, and recovery after antibiotic, radiation, or chemotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Probioflor Complex.